Novel Oxadiazole-Quinoxalines as Hybrid Scaffolds with Antitumor Activity
International Journal of Molecular Sciences · 08.02.2025 · 26 (4) · 1439
DOI: 10.3390/ijms26041439 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 08.02.2025. Verfasst von Paola Corona und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Surgery and Pharmacy, University of Sassari, 07100 Sassari, Italy. Hauptthemen laut MEDLINE: Quinoxalines, Oxadiazoles, Antineoplastic Agents. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Sassari.
Abstract (Originalsprache)
A small library of 25 novel 1,3,4-oxadiazole-quinoxalines was synthesized and evaluated in vitro for its cytotoxic activity at 10 μM concentration against nine NCI-different cancer cell lines. Among tested compounds, derivatives 24, 25, and 26 showed good inhibition percentages over different cell lines and, therefore, progressed to the full five-dose assay. Compound 24, possessing a 1,3,4-oxadiazole-core, bearing a 7-trifluoromethyl-quinoxaline nucleus on C-2 and a C-5 phenyl ring, had activity against leukemia, CNS, ovarian, renal, prostate, and breast cancer, with highest the values against breast MCF7 (GI50: 1.85 μM) and MDA-MB-468 (GI50: 1.95 μM) cell lines, showing the better MG_MID value (−5.02). These novel derivatives were able to delay the S phase of the cell cycle and induce apoptosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Surgery and Pharmacy, University of Sassari, 07100 Sassari, Italy.
- Department of Translational Medicine, University of Ferrara, 44121 Ferrara, Italy.
- Department of Medicine and Surgery, University of Parma, Via Gramsci 14, 43126 Parma, Italy.
- Department of Biomedical Sciences, University of Cagliari, Cittadella Universitaria, 09042 Monserrato, Italy.
ORCID-Profile: Paola Corona, Roberta Ibba, Stefania Merighi, Battistina Asproni, Paola Caria, Gabriele Murineddu
Förderung
- University of Sassari
Zitieren
APA
Corona, P., Gessi, S., Ibba, R., Merighi, S., Mirandola, P., Pinna, G. A., Nigro, M., Pozzi, G., Asproni, B., Travagli, A., Piras, S., Carta, A., Caria, P., & Murineddu, G. (2025). Novel Oxadiazole-Quinoxalines as Hybrid Scaffolds with Antitumor Activity. International Journal of Molecular Sciences, 26(4), 1439. https://doi.org/10.3390/ijms26041439
Vancouver
Corona P, Gessi S, Ibba R, Merighi S, Mirandola P, Pinna GA, et al. Novel Oxadiazole-Quinoxalines as Hybrid Scaffolds with Antitumor Activity. International Journal of Molecular Sciences. 2025;26(4):1439. doi:10.3390/ijms26041439
BibTeX
@article{Corona2025,
author = {Corona, Paola and Gessi, Stefania and Ibba, Roberta and Merighi, Stefania and Mirandola, Prisco and Pinna, Gérard Aimè and Nigro, Manuela and Pozzi, Giulia and Asproni, Battistina and Travagli, Alessia and Piras, Sandra and Carta, Antonio and Caria, Paola and Murineddu, Gabriele},
title = {Novel Oxadiazole-Quinoxalines as Hybrid Scaffolds with Antitumor Activity},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {4},
pages = {1439},
doi = {10.3390/ijms26041439}
}
EUVIMED